MEDICAL cannabis company Cann Group has entered a temporary share trading halt as it attempts to raise capital for its laboratories and manufacturing capability in Mildura.

The results of the capital raising are expected to be announced on Monday, with the Australian Financial Review reporting the company was aiming at $20 million.

The funds would be put towards strengthening its extraction, la...